Cargando…

Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer

Gallbladder cancer (GBC) is the leading malignancy of biliary system showing refractory chemoresistance to current first‐line drugs. Growing epidemiological evidences have established that the incidence of GBC exhibits significant gender predominance with females two‐threefold higher than males, sug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shuai, Wang, Hui, Chen, Wei, Zhan, Ming, Xu, Sunwang, Huang, Xince, Lin, Ruirong, Shen, Hui, Wang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991689/ https://www.ncbi.nlm.nih.gov/pubmed/31782270 http://dx.doi.org/10.1111/jcmm.14851

Ejemplares similares

PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2
por: Shen, Hui, et al.
Publicado: (2018)

Circular RNA circERBB2 promotes gallbladder cancer progression by regulating PA2G4-dependent rDNA transcription
por: Huang, Xince, et al.
Publicado: (2019)

PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway
por: Shen, Hui, et al.
Publicado: (2019)

Correction to: Circular RNA circERBB2 promotes gallbladder cancer progression by regulating PA2G4-dependent rDNA transcription
por: Huang, Xince, et al.
Publicado: (2022)

Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer
por: Xu, Sunwang, et al.
Publicado: (2019)

Deoxycholic acid modulates the progression of gallbladder cancer through N(6)-methyladenosine-dependent microRNA maturation
por: Lin, Ruirong, et al.
Publicado: (2020)

Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks
por: Xu, Sunwang, et al.
Publicado: (2017)

Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy
por: Xu, Sunwang, et al.
Publicado: (2021)

Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer
por: Yang, Dong, et al.
Publicado: (2020)

miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
por: Yang, Dong, et al.
Publicado: (2017)

DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer
por: Shen, Jiliang, et al.
Publicado: (2017)

Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
por: Jiang, Cen, et al.
Publicado: (2023)

SPARC promotes pancreatic cancer cell proliferation and migration through autocrine secretion into the extracellular milieu
por: Pan, Kehua, et al.
Publicado: (2021)

Luteolin inhibits pancreatitis-induced acinar-ductal metaplasia, proliferation and epithelial-mesenchymal transition of acinar cells
por: Huang, Xince, et al.
Publicado: (2018)

Glucose impairs tamoxifen responsiveness modulating connective tissue growth factor in breast cancer cells
por: Ambrosio, Maria Rosaria, et al.
Publicado: (2017)

NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK
por: Liu, Hui, et al.
Publicado: (2023)

SP/NK‐1R promotes gallbladder cancer cell proliferation and migration
por: Deng, Xue‐Ting, et al.
Publicado: (2019)

Rare sugar l-sorbose exerts antitumor activity by impairing glucose metabolism
por: Xu, Hui-Lin, et al.
Publicado: (2023)

Development and validation of a prognostic nomogram for gallbladder cancer patients after surgery
por: Xu, Xinsen, et al.
Publicado: (2022)

Maternal high-fat diet impairs glucose metabolism, β-cell function and proliferation in the second generation of offspring rats
por: Huang, Yan-Hong, et al.
Publicado: (2017)

Tamoxifen suppresses pancreatic β-cell proliferation in mice
por: Ahn, Surl-Hee, et al.
Publicado: (2019)

Tamoxifen metabolism: pharmacokinetic and in vitro study.
por: Etienne, M. C., et al.
Publicado: (1989)

Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells
por: Steifensand, Friederike, et al.
Publicado: (2021)

MiR-4733-5p promotes gallbladder carcinoma progression via directly targeting kruppel like factor 7
por: Hu, Xiaoqiang, et al.
Publicado: (2022)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania
por: Trinconi, Cristiana T., et al.
Publicado: (2018)

Tamoxifen inhibits chemokinesis in equine neutrophils
por: Morales, Natalia, et al.
Publicado: (2018)

SRC Promotes Tamoxifen Resistance in Breast Cancer via Up-Regulating SIRT1
por: Zhou, Jun, et al.
Publicado: (2020)

Combination Treatment of Tamoxifen with Risperidone in Breast Cancer
por: Yeh, Wei-Lan, et al.
Publicado: (2014)

MiR-570 inhibits cell proliferation and glucose metabolism by targeting IRS1 and IRS2 in human chronic myelogenous leukemia
por: Zhao, Hong, et al.
Publicado: (2017)

Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of IRβ
por: Zhou, Qian, et al.
Publicado: (2022)

Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex
por: Lin, Yu-Ling, et al.
Publicado: (2016)

Bmi-1 in gallbladder carcinoma: Clinicopathology and mechanism of regulation of human gallbladder carcinoma proliferation
por: Jiao, Kai, et al.
Publicado: (2019)

Effects of 17β-estradiol and tamoxifen on gastric cancer cell proliferation and apoptosis and ER-α36 expression
por: Wang, Xuming, et al.
Publicado: (2017)

Catalpol Promotes the Proliferation and Differentiation of Osteoblasts Induced by High Glucose by Inhibiting KDM7A
por: Cheng, Jian, et al.
Publicado: (2020)

Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway
por: Yang, Lihui, et al.
Publicado: (2021)

Sodium/glucose cotransporter 1-dependent metabolic alterations induce tamoxifen resistance in breast cancer by promoting macrophage M2 polarization
por: Niu, Xingjian, et al.
Publicado: (2021)

Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients
por: Zhan, Ming, et al.
Publicado: (2018)

Leuprorelin/tamoxifen: Impairment of ventricular repolarisation reserve: case report
Publicado: (2021)

miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer
por: Wang, Hui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cu9grqdmc8o66r78pdqcjlldcr